Evidence map›Paper›PMID 38819909›Full record

Observational studyJMIR mental health2024

Characterizing Longitudinal Patterns in Cognition, Mood, And Activity in Depression With 6-Week High-Frequency Wearable Assessment: Observational Study.

Francesca Cormack, Maggie McCue, Caroline Skirrow, Nathan Cashdollar, Nick Taptiklis, Tempest van Schaik, Ben Fehnert, James King, Lambros Chrones, Sara Sarkey and 2 more

Abstract readObservational Study
In one paragraph

Observational study in JMIR mental health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Francesca CormackCambridge Cognition, Cambridge, United Kingdom.ORCID 0000-0002-4413-177X
Maggie McCueTakeda Pharmaceuticals USA Inc, Lexington, MA, United States.ORCID 0000-0003-1953-1795
Caroline SkirrowCambridge Cognition, Cambridge, United Kingdom.ORCID 0000-0001-8692-7787
Nathan CashdollarCambridge Cognition, Cambridge, United Kingdom.ORCID 0000-0003-3847-7261
Nick TaptiklisCambridge Cognition, Cambridge, United Kingdom.ORCID 0000-0003-0194-9413
Tempest van SchaikCtrl Group, London, United Kingdom.ORCID 0000-0001-7745-2249
Ben FehnertCognition Kit, Cambridge, United Kingdom.ORCID 0000-0002-5371-2154
James KingCognition Kit, Cambridge, United Kingdom.ORCID 0000-0001-9969-9541
Lambros ChronesTakeda Pharmaceuticals USA Inc, Lexington, MA, United States.ORCID 0000-0001-7822-9364
Sara SarkeyTakeda Pharmaceuticals USA Inc, Lexington, MA, United States.ORCID 0000-0002-0586-265X
Jasmin KrollCambridge Cognition, Cambridge, United Kingdom.ORCID 0000-0003-3504-3281
Jennifer H BarnettCambridge Cognition, Cambridge, United Kingdom.ORCID 0000-0002-4851-5949

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCognitive symptoms are an underrecognized aspect of depression that are often untreated. High-frequency cognitive assessment holds promise for improving disease and treatment monitoring. Although we have previously found it feasible to remotely assess cognition and mood in this capacity, further work is needed to ascertain the optimal methodology to implement and synthesize these techniques.

objectiveThe objective of this study was to examine (1) longitudinal changes in mood, cognition, activity levels, and heart rate over 6 weeks; (2) diurnal and weekday-related changes; and (3) co-occurrence of fluctuations between mood, cognitive function, and activity.

methodsA total of 30 adults with current mild-moderate depression stabilized on antidepressant monotherapy responded to testing delivered through an Apple Watch (Apple Inc) for 6 weeks. Outcome measures included cognitive function, assessed with 3 brief n-back tasks daily; self-reported depressed mood, assessed once daily; daily total step count; and average heart rate. Change over a 6-week duration, diurnal and day-of-week variations, and covariation between outcome measures were examined using nonlinear and multilevel models.

resultsParticipants showed initial improvement in the Cognition Kit N-Back performance, followed by a learning plateau. Performance reached 90% of individual learning levels on average 10 days after study onset. N-back performance was typically better earlier and later in the day, and step counts were lower at the beginning and end of each week. Higher step counts overall were associated with faster n-back learning, and an increased daily step count was associated with better mood on the same (P<.001) and following day (P=.02). Daily n-back performance covaried with self-reported mood after participants reached their learning plateau (P=.01).

conclusionsThe current results support the feasibility and sensitivity of high-frequency cognitive assessments for disease and treatment monitoring in patients with depression. Methods to model the individual plateau in task learning can be used as a sensitive approach to better characterize changes in behavior and improve the clinical relevance of cognitive data. Wearable technology allows assessment of activity levels, which may influence both cognition and mood.

Indexed as

AffectWearable Electronic DevicesAdultCognitionDepressionFemaleHeart RateHumansLongitudinal StudiesMaleMiddle Agedcognitiondepressiondigital biomarkersecological momentary assessmentmobile healthremote testing

Identifiers

PMID38819909
PMCPMC11179033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.